Impact of cardiovascular comorbidities on COPD exacerbations

S. Antoniu, C. I. Andrei, R. Iulia (Iasi, Romania)

Source: Annual Congress 2007 - COPD and comorbidity
Session: COPD and comorbidity
Session type: Electronic Poster Discussion
Number: 4147
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Antoniu, C. I. Andrei, R. Iulia (Iasi, Romania). Impact of cardiovascular comorbidities on COPD exacerbations. Eur Respir J 2007; 30: Suppl. 51, 4147

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013


Factors affecting in-hospital mortality in patients with chronic obstructive pulmonary disease exacerbation
Source: Annual Congress 2013 –The latest insights in chronic care
Year: 2013

COPD and comorbidities
Source: Annual Congress 2009 - COPD comorbidities: translational approaches
Year: 2009


The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013


Impact of hyperglycaemia and comorbid diabetes mellitus on short and long-term outcome after COPD exacerbation
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013

Cardiovascular risk assessment in COPD patients with severe exacerbation
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013


Role of comorbidities on mortality in patients hospitalized for COPD exacerbations
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013

The frequency of COPD exacerbations is related to the comorbidity profile
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016

Impact of not planned readmissions due to acute exacerbations of chronic obstructive pulmonary disease
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015


Acute exacerbations of COPD: The influence of comorbidities and chronic medication on mortality and exacerbation rate
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015


Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011

Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013



Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013


Acute exacerbations of chronic obstructive pulmonary disease: Impact of cardiovascular co-morbidities
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010


Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


Statins and outcome of COPD patients after hospitalization for COPD exacerbations
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010


Differential diagnosis and impact of cardiovascular comorbidities and pulmonary embolism during COPD exacerbations
Source: Eur Respir Monogr 2017; 77: 114-128
Year: 2017